日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transcatheter aortic valve implantation and gut microbiota: Rationale and design of the 'GUT-TAVI' cohort study

经导管主动脉瓣置换术与肠道菌群: “GUT-TAVI”队列研究的理论基础和设计

Manti, Magdalini; Dimitriadis, Kyriakos; Dri, Eirini; Mavromoustakou, Kyriaki; Vakka, Angeliki; Koutsopoulos, Georgios; Tsioufis, Panagiotis; Katsimichas, Themistoklis; Siakavellas, Spyridon; Gazouli, Maria; Tsioufis, Konstantinos

Expert recommendations regarding the use of fecal calprotectin in daily clinical practice: statements of a taskforce process from the Hellenic Group for the Study of Inflammatory Bowel Disease (EOMIFNE)

关于在日常临床实践中使用粪便钙卫蛋白的专家建议:希腊炎症性肠病研究组 (EOMIFNE) 工作组的声明

Bamias, Giorgos; Fessatou, Smaragdi; Kapizioni, Christina; Kitsou, Konstantina; Kokkotis, Georgios; Kourti, Afroditi; Markopoulos, Panagiotis; Orfanoudaki, Eleni; Siakavellas, Spyros; Tzouvala, Maria

Inflammatory Bowel Disease (IBD)-Associated Colorectal Cancer (CRC): Is cGAS-STING Pathway Targeting the Key to Chemoprevention?

炎症性肠病 (IBD) 相关结直肠癌 (CRC):cGAS-STING 通路是否是化学预防的关键?

Papadakos, Stavros P; Georgiadou, Chara; Argyrou, Alexandra; Michailidou, Elisavet; Thanos, Charalampos; Vogli, Stamatina; Siakavellas, Spyros I; Manolakopoulos, Spillios; Theocharis, Stamatios

Recent advances in the diagnosis and management of amoebiasis

阿米巴病诊断和治疗的最新进展

Cooney, Joseph; Siakavellas, Spyros I; Chiodini, Peter L; Mahadeva, Ula; Godbole, Gauri; Pollok, Richard Cg; Smith, Philip J

Induction with upadacitinib in Crohn's disease: real-world experience from an early-access program in Greece

使用upadacitinib诱导治疗克罗恩病:来自希腊早期准入项目的真实世界经验

Papathanasiou, Evgenia; Ioannou, Alexandros; Pardalis, Pavlos; Leonidakis, Giorgos; Michalopoulos, George; Manolakopoulos, Spilios; Siakavellas, Spyridon; Theodoropoulou, Angeliki; Tasovasili, Athanasia; Giouleme, Olga; Tzouvala, Maria; Tsironi, Eftychia; Viazis, Nikos; Michopoulos, Spyridon; Zampeli, Evanthia

Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma

探索GITR/GITRL信号通路的作用:从肝脏疾病到肝细胞癌

Papadakos, Stavros P; Chatzikalil, Elena; Vakadaris, Georgios; Reppas, Lampros; Arvanitakis, Konstantinos; Koufakis, Theocharis; Siakavellas, Spyros I; Manolakopoulos, Spilios; Germanidis, Georgios; Theocharis, Stamatios

Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study

在慢性乙型肝炎(CHB)患者中,使用富马酸替诺福韦二吡呋酯(TDF)治疗的成功并不能保证瞬时弹性成像评估的肝损伤得到改善。一项回顾性-前瞻性多中心研究

Kranidioti, Hariklia; Zisimopoulos, Konstantinos; Oikonomou, Theodora; Voulgaris, Theodoros; Siakavellas, Spyros; Agorastou, Polixeni; Deutsch, Melanie; Triantos, Christos; Goulis, Ioannis; Papatheodoridis, George; Manolakopoulos, Spilios

Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis

苏格兰洛锡安地区过去10年IBD患者急诊入院模式:一项回顾性患病率队列分析

Lyons, Mathew; Derikx, Lauranne A A P; Fulforth, James; McCall, Sophie; Plevris, Nikolas; Jenkinson, Philip W; Kirkwood, Kathryn; Siakavellas, Spyros; Lucaciu, Laura; Constantine-Cooke, Nathan; Arnott, Ian D; Henderson, Paul; Russell, Richard K; Wilson, David C; Lees, Charlie W; Jones, Gareth-Rhys

Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort

预测溃疡性结肠炎患者对维多珠单抗反应的因素:来自希腊 VEDO-IBD 队列研究的结果

Bamias, Giorgos; Kokkotis, Georgios; Gizis, Michalis; Kapizioni, Christina; Karmiris, Konstantinos; Koureta, Evgenia; Kyriakos, Nikolaos; Leonidakis, Georgios; Makris, Konstantinos; Markopoulos, Panagiotis; Michalopoulos, Georgios; Michopoulos, Spyridon; Papaconstantinou, Ioannis; Polymeros, Dimitrios; Siakavellas, Spyros I; Triantafyllou, Konstantinos; Tsironi, Eftychia; Tsoukali, Emmanouela; Tzouvala, Maria; Viazis, Nikos; Xourafas, Vassileios; Zacharopoulou, Eirini; Zampeli, Evanthia; Zografos, Konstantinos; Papatheodoridis, George; Mantzaris, Gerasimos

Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts

阿达木单抗生物类似药SB5在炎症性肠病中的有效性和安全性:从原研药转换为SB5、双重生物类似药转换以及未接受过生物类似药治疗的SB5观察性队列的研究结果

Derikx, Lauranne A A P; Dolby, Heather W; Plevris, Nikolas; Lucaciu, Laura; Rees, Caitlin S; Lyons, Mathew; Siakavellas, Spyros I; Constantine-Cooke, Nathan; Jenkinson, Philip; Su, Shanna; O'Hare, Claire; Kirckpatrick, Laura; Merchant, Lynne M; Noble, Colin; Arnott, Ian D; Jones, Gareth-Rhys; Lees, Charlie W